KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cme Group (CME) Share-based Compensation: 2009-2025

Historic Share-based Compensation for Cme Group (CME) over the last 16 years, with Sep 2025 value amounting to $24.0 million.

  • Cme Group's Share-based Compensation rose 18.23% to $24.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $93.0 million, marking a year-over-year increase of 7.27%. This contributed to the annual value of $89.5 million for FY2024, which is 7.96% up from last year.
  • Per Cme Group's latest filing, its Share-based Compensation stood at $24.0 million for Q3 2025, which was up 15.94% from $20.7 million recorded in Q2 2025.
  • Cme Group's Share-based Compensation's 5-year high stood at $27.1 million during Q4 2024, with a 5-year trough of $15.6 million in Q3 2021.
  • In the last 3 years, Cme Group's Share-based Compensation had a median value of $20.7 million in 2025 and averaged $21.7 million.
  • Its Share-based Compensation has fluctuated over the past 5 years, first slumped by 34.45% in 2021, then surged by 37.10% in 2022.
  • Quarterly analysis of 5 years shows Cme Group's Share-based Compensation stood at $18.6 million in 2021, then spiked by 37.10% to $25.5 million in 2022, then decreased by 4.71% to $24.3 million in 2023, then climbed by 11.52% to $27.1 million in 2024, then increased by 18.23% to $24.0 million in 2025.
  • Its Share-based Compensation stands at $24.0 million for Q3 2025, versus $20.7 million for Q2 2025 and $21.2 million for Q1 2025.